FRESENIUS MEDICAL CARE AG (1FME.MI) Stock Fundamental Analysis

BIT:1FME • DE0005785802

40.54 EUR
+0.14 (+0.35%)
Last: Feb 18, 2026, 07:00 PM
Fundamental Rating

5

Taking everything into account, 1FME scores 5 out of 10 in our fundamental rating. 1FME was compared to 32 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of 1FME get a neutral evaluation. Nothing too spectacular is happening here. 1FME has a correct valuation and a medium growth rate. 1FME also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year 1FME was profitable.
  • In the past year 1FME had a positive cash flow from operations.
  • In the past 5 years 1FME has always been profitable.
  • In the past 5 years 1FME always reported a positive cash flow from operatings.
1FME.MI Yearly Net Income VS EBIT VS OCF VS FCF1FME.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

  • 1FME has a Return On Assets (2.33%) which is comparable to the rest of the industry.
  • 1FME has a Return On Equity (5.55%) which is in line with its industry peers.
  • With a Return On Invested Capital value of 3.95%, 1FME is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
  • 1FME had an Average Return On Invested Capital over the past 3 years of 3.14%. This is below the industry average of 6.99%.
  • The 3 year average ROIC (3.14%) for 1FME is below the current ROIC(3.95%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.33%
ROE 5.55%
ROIC 3.95%
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1FME.MI Yearly ROA, ROE, ROIC1FME.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • The Profit Margin of 1FME (3.66%) is better than 65.63% of its industry peers.
  • 1FME's Profit Margin has declined in the last couple of years.
  • 1FME has a Operating Margin (7.19%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of 1FME has declined.
  • 1FME has a Gross Margin of 25.00%. This is comparable to the rest of the industry: 1FME outperforms 56.25% of its industry peers.
  • 1FME's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 7.19%
PM (TTM) 3.66%
GM 25%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
1FME.MI Yearly Profit, Operating, Gross Margins1FME.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1FME is destroying value.
  • 1FME has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, 1FME has less shares outstanding
  • The debt/assets ratio for 1FME has been reduced compared to a year ago.
1FME.MI Yearly Shares Outstanding1FME.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
1FME.MI Yearly Total Debt VS Total Assets1FME.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 2.20 indicates that 1FME is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of 1FME (2.20) is better than 65.63% of its industry peers.
  • 1FME has a debt to FCF ratio of 5.97. This is a neutral value as 1FME would need 5.97 years to pay back of all of its debts.
  • 1FME has a Debt to FCF ratio of 5.97. This is in the better half of the industry: 1FME outperforms 71.88% of its industry peers.
  • A Debt/Equity ratio of 0.73 indicates that 1FME is somewhat dependend on debt financing.
  • 1FME's Debt to Equity ratio of 0.73 is fine compared to the rest of the industry. 1FME outperforms 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 5.97
Altman-Z 2.2
ROIC/WACC0.68
WACC5.78%
1FME.MI Yearly LT Debt VS Equity VS FCF1FME.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.3 Liquidity

  • A Current Ratio of 1.36 indicates that 1FME should not have too much problems paying its short term obligations.
  • 1FME's Current ratio of 1.36 is fine compared to the rest of the industry. 1FME outperforms 68.75% of its industry peers.
  • A Quick Ratio of 1.00 indicates that 1FME may have some problems paying its short term obligations.
  • 1FME's Quick ratio of 1.00 is fine compared to the rest of the industry. 1FME outperforms 65.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1
1FME.MI Yearly Current Assets VS Current Liabilites1FME.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

5

3. Growth

3.1 Past

  • 1FME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.77%, which is quite good.
  • 1FME shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.43% yearly.
  • 1FME shows a small growth in Revenue. In the last year, the Revenue has grown by 2.10%.
  • The Revenue has been growing slightly by 2.04% on average over the past years.
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.73% on average over the next years. This is quite good.
  • 1FME is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.08% yearly.
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y13.73%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y4.08%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1FME.MI Yearly Revenue VS Estimates1FME.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B 20B 25B
1FME.MI Yearly EPS VS Estimates1FME.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 10.78, the valuation of 1FME can be described as reasonable.
  • Based on the Price/Earnings ratio, 1FME is valued cheaply inside the industry as 90.63% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.10. 1FME is valued rather cheaply when compared to this.
  • 1FME is valuated reasonably with a Price/Forward Earnings ratio of 9.78.
  • Based on the Price/Forward Earnings ratio, 1FME is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
  • 1FME's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 10.78
Fwd PE 9.78
1FME.MI Price Earnings VS Forward Price Earnings1FME.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as 1FME.
  • 1FME's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 13.56
EV/EBITDA 10.55
1FME.MI Per share data1FME.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • 1FME's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as 1FME's earnings are expected to grow with 13.16% in the coming years.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y12.96%
EPS Next 3Y13.16%

7

5. Dividend

5.1 Amount

  • 1FME has a Yearly Dividend Yield of 3.54%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.65, 1FME pays a better dividend. On top of this 1FME pays more dividend than 93.75% of the companies listed in the same industry.
  • 1FME's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
Industry RankSector Rank
Dividend Yield 3.54%

5.2 History

  • The dividend of 1FME has a limited annual growth rate of 0.31%.
Dividend Growth(5Y)0.31%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 58.83% of the earnings are spent on dividend by 1FME. This is a bit on the high side, but may be sustainable.
  • The dividend of 1FME is growing, but earnings are growing more, so the dividend growth is sustainable.
DP58.83%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
1FME.MI Yearly Income VS Free CF VS Dividend1FME.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
1FME.MI Dividend Payout.1FME.MI Dividend Payout, showing the Payout Ratio.1FME.MI Dividend Payout.PayoutRetained Earnings

FRESENIUS MEDICAL CARE AG

BIT:1FME (2/18/2026, 7:00:00 PM)

40.54

+0.14 (+0.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04
Earnings (Next)02-24
Inst Owners43.88%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.79B
Revenue(TTM)19.64B
Net Income(TTM)718.19M
Analysts57.93
Price Target47.84 (18.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.54%
Yearly Dividend1.19
Dividend Growth(5Y)0.31%
DP58.83%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.52%
Min EPS beat(2)14.16%
Max EPS beat(2)14.89%
EPS beat(4)4
Avg EPS beat(4)17.81%
Min EPS beat(4)14.16%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)16.37%
EPS beat(12)10
Avg EPS beat(12)13.79%
EPS beat(16)12
Avg EPS beat(16)10.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.52%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)-1.71%
Revenue beat(4)2
Avg Revenue beat(4)0.94%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)0%
PT rev (3m)-3.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.91%
EPS NY rev (1m)0%
EPS NY rev (3m)2.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.37%
Valuation
Industry RankSector Rank
PE 10.78
Fwd PE 9.78
P/S 1.21
P/FCF 13.56
P/OCF 9.47
P/B 1.84
P/tB N/A
EV/EBITDA 10.55
EPS(TTM)3.76
EY9.27%
EPS(NY)4.15
Fwd EY10.23%
FCF(TTM)2.99
FCFY7.38%
OCF(TTM)4.28
OCFY10.55%
SpS33.47
BVpS22.07
TBVpS-3.21
PEG (NY)0.5
PEG (5Y)N/A
Graham Number43.21
Profitability
Industry RankSector Rank
ROA 2.33%
ROE 5.55%
ROCE 5.62%
ROIC 3.95%
ROICexc 4.26%
ROICexgc 11.65%
OM 7.19%
PM (TTM) 3.66%
GM 25%
FCFM 8.93%
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score5
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 5.97
Debt/EBITDA 3.12
Cap/Depr 47.15%
Cap/Sales 3.85%
Interest Coverage 3.87
Cash Conversion 83.24%
Profit Quality 244.33%
Current Ratio 1.36
Quick Ratio 1
Altman-Z 2.2
F-Score5
WACC5.78%
ROIC/WACC0.68
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y13.73%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y4.08%
EBIT growth 1Y-3.43%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.22%
EBIT Next 3Y29.78%
EBIT Next 5Y18.68%
FCF growth 1Y-5.89%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y0.06%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%

FRESENIUS MEDICAL CARE AG / 1FME.MI FAQ

What is the fundamental rating for 1FME stock?

ChartMill assigns a fundamental rating of 5 / 10 to 1FME.MI.


Can you provide the valuation status for FRESENIUS MEDICAL CARE AG?

ChartMill assigns a valuation rating of 6 / 10 to FRESENIUS MEDICAL CARE AG (1FME.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for FRESENIUS MEDICAL CARE AG?

FRESENIUS MEDICAL CARE AG (1FME.MI) has a profitability rating of 4 / 10.


What are the PE and PB ratios of FRESENIUS MEDICAL CARE AG (1FME.MI) stock?

The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (1FME.MI) is 10.78 and the Price/Book (PB) ratio is 1.84.


Can you provide the financial health for 1FME stock?

The financial health rating of FRESENIUS MEDICAL CARE AG (1FME.MI) is 5 / 10.